Elliot Wilbur

Stock Analyst at Raymond James

(1.28)
# 3,459
Out of 4,876 analysts
55
Total ratings
32.61%
Success rate
-1.7%
Average return

Stocks Rated by Elliot Wilbur

ADMA Biologics
May 8, 2025
Maintains: Strong Buy
Price Target: $25$32
Current: $18.16
Upside: +76.21%
ANI Pharmaceuticals
Sep 18, 2024
Maintains: Outperform
Price Target: $81$83
Current: $65.50
Upside: +26.72%
Sol-Gel Technologies
Aug 19, 2024
Downgrades: Outperform
Price Target: $60$40
Current: $7.32
Upside: +446.45%
Organon & Co.
Mar 16, 2023
Initiates: Outperform
Price Target: $33
Current: $9.86
Upside: +234.69%
Perrigo Company
Mar 6, 2023
Maintains: Outperform
Price Target: $42$43
Current: $26.54
Upside: +62.02%
PolyPid
Sep 6, 2022
Downgrades: Outperform
Price Target: $450$120
Current: $3.57
Upside: +3,261.34%
Viatris
Mar 1, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $9.01
Upside: -
Teva Pharmaceutical Industries
Oct 28, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $16.76
Upside: -
Zoetis
Jul 16, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $156.17
Upside: -
Elanco Animal Health
Jan 10, 2020
Initiates: Market Perform
Price Target: n/a
Current: $14.29
Upside: -
Upgrades: Market Perform
Price Target: n/a
Current: $7.14
Upside: -
Downgrades: Market Perform
Price Target: n/a
Current: $23.08
Upside: -